Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

(Image: Getty/Oskanov)

FDA observes manipulation of data at Immunomedics facility

Following the US FDA issuing a CRL to Immunomedics, the agency has revealed its inspection found instances of data integrity breaches and manipulation.

‘The orchestrators of the immune system’: Partnership develops antibody therapies

Verseau and 3SBio partner to develop and commercialize monoclonal antibodies for the treatment of cancer, immune and inflammatory diseases.

Biosimilar entry into US insulin market will see ‘millions more patients treated’

The US market for insulin biosimilars is set to open up in 2020, and the head of biopharmaceuticals at Sandoz explained why he is confident of an ‘acceleration’ of the US biosimilar market in the coming years.

Clinigen pays Novartis $210m for US rights to Proleukin

Clinigen has agreed to acquire the global rights for Proleukin, after Novartis accepted a $210m fee in exchange for the asset.

WuXi Biologics enters first commercial manufacturing agreement

WuXi Biologics agrees five-year deal with Amicus for the commercial production of a biologic for the treatment of Pompe disease.

Global Industry News

Hot Topics

Spotlight

(Image: Getty/peopleimages)

Biotech licenses protein production tech to Eli Lilly

(Image: Getty/Rawpixel Ltd)

Samsung Bioepis expands in China with second partner in two months

(Image: Getty/hailshadow)

AbbVie enters $90m agreement to develop multiple myeloma immunotherapy

(Image: Getty/ SCIEPRO/SCIENCE PHOTO LIBRARY)

CAR-T for solid tumors drives industry to innovate

(Image: Getty/Design Cells)

Sanofi nanobody drug first approved to treat rare blood disorder

Follow us

Products

View more

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics